School of Medicine

The School of Medicine has established the Neurofibromatosis Center to foster collaborative and interdisciplinary research on the disorder.

The study was published in the journal Cancer Research and suggests where researchers should look for more promising treatment approaches.

Researchers say it successfully mimics the human condition and provides unique insight into tumor development, diagnosis and treatment.

World-class cancer care will come to the campus of Barnes-Jewish St. Peters Hospital this fall with the advent of a $7 million center.

Photo by Robert BostonEmil Unanue helps unveil a portrait of Charles Kilo and thanks him for his years of support of the Department of Pathology.

You could say that the Human Genome Project missed 99 percent of the genes in the adult body. That’s because it didn’t sequence genes belonging to the vast communities of bacteria that normally live on and in us. Now a $1.45 million grant from the W.M. Keck Foundation to researchers at the School of Medicine will help fill this gap by funding a study to develop new approaches for isolating, sequencing and analyzing the genomes of “friendly” bacteria that inhabit the intestine and identifying the natural metabolic products that they synthesize in their native gut habitats.

Scientists at the School of Medicine used genetically modified mice to uncover a potentially important link between diabetes and obesity.

A new procedure holds promise for treatment of blood and bone marrow disorders, immune dysfunction and certain metabolic disorders.

The Radiological Society of North America comprises more than 37,000 radiologists, radiation oncologists and related scientists.

Researchers have developed “direct genomic selection”; it could provide the leads they need to understand and treat a wide range of disorders. More medical news